Clinical Trials Logo

Clinical Trial Summary

The project will develop knowledge about physical activity in persons with Charcot-Marie-Tooth (CMT) in Norway. We plan to explore instruments to measure physical activity level for the target-group at the community level. We want to understand which type of activities, activity intensities and how persons with CMT perform habitual physical activity. Subsequently, a physical activity measurement instrument adapted to persons with CMT will be developed. This instrument can be used in a future intervention project to promote physical activity in this group.


Clinical Trial Description

Charcot-Marie-Tooth (CMT) is a condition that potentially affects daily life function including physical activity. Currently, there is no specific treatment. To prevent physical deconditioning, physical activity recommended. Furthermore, other studies have found the benefit of being physically active, including people with neuromuscular disorders (NMD). . Apart from the physical activity in a rehabilitation center, physical activity also needs to be maintained at the community level in people's everyday life. To measure physical activity level in the community, we need an instrument that is designed for doing so. A questionnaire can be used to collect information about type of activity, activity duration and intensity. The instruments available so far to measure physical activity at the community level are not specifically adapted to persons with CMT. Therefore, this study will focus on revising the questionnaire based on the inputs from persons with CMT themselves. Furthermore, the revised questionnaire will be compared with the original one in addition to yet another instrument. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04461613
Study type Interventional
Source Oslo University Hospital
Contact
Status Enrolling by invitation
Phase N/A
Start date September 15, 2020
Completion date April 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT06040567 - Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Enrolling by invitation NCT06359561 - Assessment of Effectiveness and Stimulation Coverage of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Patients With Cervical Lead Placement
Recruiting NCT06044662 - Prognostic Value of Biomarkers in Polyneuropathy.
Completed NCT00050245 - Rituximab to Treat Neuropathy With Anti-MAG Antibodies Phase 2
Not yet recruiting NCT01718015 - Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy N/A
Completed NCT03765489 - Electrical Muscle Stimulation in the Development of Acquired Weakness in Patients With Severe Sepsis and Septic Shock N/A
Completed NCT01370837 - Neurogenic Inflammation in Diabetes N/A
Not yet recruiting NCT02061059 - Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes N/A
Recruiting NCT06377033 - Using the EHR to Advance Genomic Medicine Across a Diverse Health System N/A
Not yet recruiting NCT06390527 - Ultrasonography in Diagnosis of Polyneuropathy
Recruiting NCT05188690 - Polyneuropathy and COVID-19
Completed NCT00231673 - A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy Phase 2
Recruiting NCT03237494 - TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
Active, not recruiting NCT03617185 - Effect of Exercise and Surgical Weight Loss on Polyneuropathy N/A
Active, not recruiting NCT02753036 - Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer
Completed NCT01263132 - Neuropathic Pain Management Phase 3
Terminated NCT01867645 - The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis Phase 1
Completed NCT00162968 - Escitalopram as a Treatment for Pain in Polyneuropathy Phase 4
Completed NCT04664426 - Sensory Neuropathy Scores Validated by Quantitative Sensory Testing and Nerve Conduction Studies for Kidney Transplant Recipients
Recruiting NCT05023889 - Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy Early Phase 1